公共娱乐

Improve core competitiveness
Build up the system of technology, quality and EHS

Apeloa has various R&D facilities in the cities of Hengdian, Hangzhou, Shanghai and Chengdu, mainly focused in the innovation of chemical synthesis, biotechnology and pharmaceutical engineering. The research institute has been equipped with state-of-art instruments such as NMR, LC-MS, ICP-MS, etc. Currently, there are over 400 scientists in the institute including a group of the high level research professionals with western education background and working experience in multi-national pharmaceutical companies. We are committed and endeavor to the development of novel therapeutic medicines, specifically in the field of cardiovascular, infectious disease and oncology, to improve people’s living quality.

API Technology Center, Engineering Technology Center, CDMO R&D Center and Yosemade Medicine Research Institute carry out scientific research activities for the three business divisions at Apeloa individually and they are the major driving force for Apeloa to reach its business achievement.

Apeloa has built strong external collaboration with academies, biotech, and other research institutions. The Academician Station and Post-doctoral Station in Apeloa attract the top talents throughout the world and makes Apeloa as an outstanding platform for innovation

Overview

National-recognized Enterprises Technology Center
National Post-Doctoral Work Station
Provincial Academician Work Station
2 Experts in The Recruitment Program of Global Experts of Zhejiang Province
National Hi-tech Enterprise


Organization

公共娱乐(中国)官网登录入口 

R&D Capability


52 Research Scientists (7 Ph.D., 6 Masters)
5 labs, including 50 fume hoods
1 small pilot lab, equipped with 20L-50L reactors
1 high-pressure reaction lab
National Hi-Tech Enterprise



Synthetic route research
Process research and optimization
Impurity study and polymorphism research
Small pilot, pilot, and trial production
Engineering design
公共娱乐(中国)官网登录入口


Expertise


Extensive experience on organic synthesis
R&D team with decades of experience and platform with well technology communication
Qualification on using highly toxic compounds
Application condition and experience on special material
Recycling and treating on special by-product and waste product

Engineering Technology Platform Building
TFRR, crystallization, extraction, distillation, drying, solid-liquid separation, membrane techology, automation technology and material compatibility study, and etc

Comprehensive science research database
Reaxys, Scifinder, CNKI…

CopyRight ? 2017 APELOA ZheICP13019407-1ZheICP13019407-1 Powered by:HANSUN
【网站地图】【sitemap】